CMS will conduct a demonstration that will implement a prior authorization 
process for certain medical equipment for all people with Medicare who reside 
in seven states with high populations of fraud- and error-prone providers 
(California, Florida, Illinois, Michigan, New York, North Carolina, and Texas). 
This is an important step toward paying appropriately for certain medical 
equipment that has a high error rate. This demonstration will help ensure that 
a beneficiary's medical condition warrants their medical equipment under 
existing coverage guidelines. Moreover, the program will assist in preserving a 
Medicare beneficiary's right to receive quality products from accredited 
suppliers. This demonstration will begin Summer 2012.

To read more about the demonstration, visit the Prior Authorization of Power 
Mobility Devices (PMD) Demonstration 
webpage<http://www.cms.gov/Research-Statistics-Data-and-Systems/Monitoring-Programs/CERT/PADemo.html>.
 Stakeholders may submit questions to 
[email protected]<mailto:[email protected]<mailto:[email protected]%3cmailto:[email protected]>>.

________________________________

If you know someone who would like to subscribe to a Medicare Fee-For-Service 
(FFS) provider listserv, go to 
http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads//MailingLists_FactSheet.pdf<http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/MailingLists_FactSheet.pdf>
 .



If you would like to unsubscribe from a specific provider listserv, please go 
to (https://list.nih.gov/cgi-bin/wa.exe?INDEX) to unsubscribe or to leave the 
appropriate listserv.



Please DO NOT respond to this email. This email is a service of CMS and routed 
through an electronic mail server to communicate Medicare policy and 
operational changes and/or updates. Responses to this email are not routed to 
CMS personnel. Inquiries may be sent by going to 
(http://www.cms.gov/About-CMS/Agency-Information/ContactCMS/index.html).   
Thank you.


Reply via email to